Table 2 Peptide segments were observed by nanoLC–MS/MS
No. | Sequence | No. | Sequence | No. | Sequence |
|---|---|---|---|---|---|
1 | APIVTCR | 13 | SGDPHRYFAGDHIR | 25 | GGPTPIR |
2 | APIVTCRPK | 14 | YFAGDHIR | 26 | GGPTPIRVVYANSR |
3 | APIVTCRPKLDGR | 15 | YFAGDHIRWGVNNCDK | 27 | VVYANSR |
4 | LDGREKPFK | 16 | WGVNNCDK | 28 | GAVQYCGVMTHSK |
5 | EKPFKVDVATAQAQAR | 17 | WGVNNCDKADAILWEYPIYWVGK | 29 | GAVQYCGVMTHSKVDK |
6 | PFKVDVATAQAQAR | 18 | ADAILWEYPIYWVGK | 30 | GAVQYCGVMTHSKVDKNNQGK |
7 | VDVATAQAQAR | 19 | ADAILWEYPIYWVGKNAEWAK | 31 | VDKNNQGK |
8 | VDVATAQAQARK | 20 | NAEWAKDVK | 32 | VDKNNQGKEFFEK |
9 | KAGLTTGK | 21 | NAEWAKDVKTSQQK | 33 | NNQGKEFFEK |
10 | KAGLTTGKSGDPHR | 22 | DVKTSQQK | 34 | EFFEKCDHHHHHH |
11 | AGLTTGK | 23 | DVKTSQQKGGPTPIR | ||
12 | AGLTTGKSGDPHR | 24 | TSQQKGGPTPIR |